首页> 外文期刊>British Journal of Dermatology >Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study.
【24h】

Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study.

机译:一项观察性研究表明,由于治疗停顿后症状复发很常见,因此有妄想感染(妄想寄生虫病)的患者通常需要延长治疗时间。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Delusional infestation (DI) is an uncommon psychiatric disorder in which patients present with the false and fixed belief of infestation. Numerous studies have demonstrated improvement with pharmacological treatment; however, recurrence rates on cessation of treatment remain unknown. OBJECTIVES: To assess the clinical response and recurrence rates following treatment for DI. METHODS: All patients with DI seen in our combined dermatology/psychiatry clinic to date (n=73) were offered pharmacological therapy. Patients were contacted to complete a telephone questionnaire to assess clinical outcomes, including remission and recurrence rates following treatment. RESULTS: Fifty-nine of 73 (81%) patients with DI received treatment, of whom 40/59 (68%) reported improvement or resolution of symptoms, and the remaining 19/59 (32%) failed to respond. Fifteen of 40 patients with DI completed a course of treatment, 12/40 patients are still undergoing treatment, and outcomes are unknown for 13/40. Of those who completed treatment, 11/15 (73%) reported total remission for at least 9months after discontinuing treatment (range 9months-2.5years). Recurrence of symptoms occurred in 4/15 (27%) within 4months of stopping treatment. CONCLUSIONS: Pharmacological treatment of DI can be effective, particularly in a combined dermatology/psychiatry clinic. Most treated patients have a good prognosis, and a remission period can be expected. However, more than 25% of patients may relapse on stopping treatment, with the greatest risk being within the first few months of discontinuation. These patients may require longer treatment courses, or long-term maintenance therapy for symptom control, although further studies are needed to provide recommended guidelines on drug and dosing regimen.
机译:背景:妄想症(DI)是一种罕见的精神疾病,患者表现出错误和固定的感染观念。许多研究表明,药物治疗可以改善病情。但是,停止治疗的复发率仍然未知。目的:评估DI治疗后的临床反应和复发率。方法:迄今为止,我们在皮肤病/精神病学联合诊所中所见的所有DI患者(n = 73)均接受了药物治疗。与患者联系完成电话问卷,以评估临床结果,包括治疗后的缓解率和复发率。结果:73名DI患者中有59名(81%)接受了治疗,其中40/59名(68%)报告的症状得到改善或缓解,其余19/59名(32%)没有反应。 40例DI患者中有15例完成了一个疗程,12/40例患者仍在接受治疗,13/40的预后未知。在完成治疗的患者中,有11/15(73%)报告中断治疗后至少9个月(9个月至2.5年)的总缓解。停止治疗后4个月内,有4/15(27%)的症状复发。结论:DI的药理学治疗可能是有效的,尤其是在皮肤病/精神病学联合诊所中。大多数接受治疗的患者预后良好,可以预期缓解期。但是,超过25%的患者在停止治疗后可能会复发,最大的风险是在停药的最初几个月内。这些患者可能需要更长的疗程或长期的症状控制治疗,尽管还需要进一步的研究以提供有关药物和给药方案的推荐指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号